| Detected | Trial | Change |
|---|---|---|
| 2026-07-21 | NCT06649695 A Phase II Trial of Teclistamab in Participants With Previously Treated Immunoglobulin… |
overall status: Recruiting → Active, Not Recruiting |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 3 | |||
| NCT06932562 | A Study to Learn How Safe and How Well Linvoseltamab Works Compared to Standard Treatment… | Multiple Myeloma | Recruiting |
| NCT05243797 | Phase 3 Study of Teclistamab in Combination With Lenalidomide and Teclistamab Alone… | Multiple Myeloma | Recruiting |
| NCT05028348 | A Study of Combination of Selinexor, Pomalidomide, and Dexamethasone (SPd) Versus… | Multiple Myeloma | Active, Not Recruiting |
| NCT04483739 | Isa-KRd vs KRd in Newly Diagnosed Multiple Myeloma Patients Eligible for Autologous Stem… | Multiple Myeloma | Active, Not Recruiting |
| Phase 2 | |||
| NCT07107529 | Study for Frail Patients With Newly Diagnosed Multiple Myeloma Treated With Daratumumab… | Multiple Myeloma (MM) | Recruiting |
| NCT03896737 | Daratumumab-bortezomib-dexamethasone (Dara-VCd) vs Bortezomib-Thalidomide-Dexamethasone… | Multiple Myeloma | Active, Not Recruiting |
| NCT06649695 | A Phase II Trial of Teclistamab in Participants With Previously Treated Immunoglobulin… | AL Amyloidosis | Active, Not Recruiting |
| Not specified | |||
| NCT06237803 | European Myeloma Network (EMN) Sample Project | Multiple Myeloma | Recruiting |